Retrospective Study
Copyright ©The Author(s) 2021.
World J Hepatol. Jan 27, 2022; 14(1): 260-273
Published online Jan 27, 2022. doi: 10.4254/wjh.v14.i1.260
Table 5 The association of clinicopathological factors and hepatitis B surface antigen expression patterns with viral response and serological response

HBeAg positive (n = 86)
HBeAg negative (n = 54)
Parameters
VR
SR
VR

HR (95%CI)
P value1
P value2
HR (95%CI)
P value1
P value2
HR (95%CI)
P value2
Age (yr)0.685 (0.228-2.055)0.0010.4490.892 (0.301-2.644)0.0070.8370.936 (0.460-1.904)0.855
Gender: male vs female0.581 (0.301-1.121)0.720.1050.516 (0.251-1.062)0.790.0722.410 (0.986-5.985)0.054
HBV DNA (log10IU/mL)0.782 (0.275-2.224)0.0030.6450.707 (0.246-2.029)0.400.5190.620 (0.255-1.508)0.292
HBsAg (log10IU/mL)1.931 (0.757-4.923)0.0010.1682.252 (0.878-5.773)0.0010.0910.700 (0.294-1.669)0.422
ALT ≥ 200 IU/L vs < 200 IU/L0.992 (0.476-2.068)0.900.9821.037 (0.436-2.471)0.0180.9340.854 (0.372-1.962)0.710
INR0.539 (0.271-1.072)0.7510.0780.493 (0.222-1.092)0.9010.0811.815 (0.791-4.161)0.159
Platelets (× 103/μL)0.619 (0.309-1.240)0.1940.1760.538 (0.243-1.189)0.3890.1250.925 (0.452-1.892)0.831
HAI score ≥ 9 vs < 91.566 (0.692-3.546)0.2820.2822.881 (1.170-7.094)0.1320.0216.876 (2.219-21.309)0.001
Fibrosis ≥ 4 vs < 41.245 (0.517-2.999)0.0210.6251.079 (0.427-2.730)0.0920.8720.833 (0.326-2.125)0.702
p-HBsAg3.178 (1.582-6.387)0.0010.0013.990 (1.843-8.638)0.0010.0011.089 (0.575-2.063)0.793
SP10.899 (0.495-1.634)0.0010.7273.760 (1.742-7.861)0.0010.5310.959 (0.443-2.167)0.990
SP20.727 (0.240-2.200)0.0010.5730.721 (0.216-2.410)0.0010.5950.996 (0.552-1.798)0.990
Membranous expression1.085 (0.513-2.294)0.0010.8311.082 (0.472-2.482)0.0010.9520.692 (0.246-1.944)0.485